SignatureFD’s Alaunos Therapeutics TCRT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112 | Hold |
23
| – | – | ﹤0.01% | 3188 |
|
|
2025
Q1 | $34 | Hold |
23
| – | – | ﹤0.01% | 3277 |
|
|
2024
Q4 | $44 | Hold |
23
| – | – | ﹤0.01% | 3255 |
|
|
2024
Q3 | $74 | Hold |
23
| – | – | ﹤0.01% | 3185 |
|
|
2024
Q2 | $163 | Hold |
23
| – | – | ﹤0.01% | 3054 |
|
|
2024
Q1 | $422 | Hold |
23
| – | – | ﹤0.01% | 3039 |
|
|
2023
Q4 | $247 | Sell |
23
-1
| -4% | -$11 | ﹤0.01% | 3034 |
|
|
2023
Q3 | $468 | Hold |
24
| – | – | ﹤0.01% | 3023 |
|
|
2023
Q2 | $1.81K | Hold |
24
| – | – | ﹤0.01% | 2833 |
|
|
2023
Q1 | $2.24K | Hold |
24
| – | – | ﹤0.01% | 2770 |
|
|
2022
Q4 | $2.3K | Sell |
24
-8
| -25% | -$768 | ﹤0.01% | 2759 |
|
|
2022
Q3 | $8K | Buy |
32
+8
| +33% | +$2K | ﹤0.01% | 2203 |
|
|
2022
Q2 | $4K | Hold |
24
| – | – | ﹤0.01% | 2547 |
|
|
2022
Q1 | $2K | Buy |
24
+1
| +4% | +$83 | ﹤0.01% | 2854 |
|
|
2021
Q4 | $4K | Sell |
23
-113
| -83% | -$19.7K | ﹤0.01% | 2513 |
|
|
2021
Q3 | $37K | Buy |
136
+54
| +66% | +$14.7K | ﹤0.01% | 1462 |
|
|
2021
Q2 | $33K | Hold |
82
| – | – | ﹤0.01% | 1490 |
|
|
2021
Q1 | $44K | Sell |
82
-2
| -2% | -$1.07K | ﹤0.01% | 1228 |
|
|
2020
Q4 | $32K | Buy |
84
+61
| +265% | +$23.2K | ﹤0.01% | 1276 |
|
|
2020
Q3 | $9K | Sell |
23
-3
| -12% | -$1.17K | ﹤0.01% | 1682 |
|
|
2020
Q2 | $13K | Sell |
26
-6
| -19% | -$3K | ﹤0.01% | 1476 |
|
|
2020
Q1 | $12K | Buy |
32
+9
| +39% | +$3.38K | ﹤0.01% | 1412 |
|
|
2019
Q4 | $17K | Hold |
23
| – | – | ﹤0.01% | 1332 |
|
|
2019
Q3 | $15K | Hold |
23
| – | – | ﹤0.01% | 1321 |
|
|
2019
Q2 | $20K | Hold |
23
| – | – | ﹤0.01% | 1204 |
|
|
2019
Q1 | $13K | Hold |
23
| – | – | ﹤0.01% | 1331 |
|
|
2018
Q4 | $7K | Hold |
23
| – | – | ﹤0.01% | 1463 |
|
|
2018
Q3 | $11K | Hold |
23
| – | – | ﹤0.01% | 1368 |
|
|
2018
Q2 | $11K | Buy |
+23
| New | +$11K | ﹤0.01% | 1369 |
|
|
2016
Q4 | – | Sell |
-10
| Closed | -$8K | – | 1103 |
|
|
2016
Q3 | $8K | Buy |
+10
| New | +$8K | ﹤0.01% | 1103 |
|